Skip to content

Effects of adding steroids with routine medication of ova formation in patients who have difficulty in normal production of ovum.

The efficacy of adding Dexamethasone with Clomiphene citrate in PCOS patients undergoing ovulation induction. A Randomised controlled trial. - DexCc Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/10/010225
Enrollment
90
Registered
2017-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Polycystic Ovarian Syndrome (PCOS)

Interventions

Intervention1: Tab Dexamethasone 2 mg: Tab Dexamethasone 2 mg for 13-15 days, in addition to Tab Clomiphene Citrate 100 mg for 5 days. Intervention2: Tab Dexamethasone 1 mg: Tab Dexamethasone 1 mg for

Sponsors

Research Fund Bangalore Baptist Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria (all criteria must be met): 1. Patients will be diagnosed as having PCOS according to the Rotterdam criteria for diagnosis of PCOS.26 2. All patients would have previously received CC 100 mg daily for 5 days per cycle and would have shown no response to this dose. 3. Semen analysis for their partners would have been evaluated according to the modified criteria of World Health Organization (2010) and found normal. 4. Age between 18 and 39 years. 5. Period of infertility >1 year.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients with hyperprolactinaemia, hypercortisolism, diabetes mellitus and thyroid dysfunction. 2. Patients receiving medications such as cholesterol-lowering drugs, beta-blockers and tricyclic antidepressants will also be excluded. 3. History of pelvic surgery or infertility factor other than anovulation.

Design outcomes

Primary

MeasureTime frame
1. The primary outcome would be the ovulation rate in the treatment cycle.Timepoint: 1. The primary outcome would be assessed from 13-17 day of the cycle.

Secondary

MeasureTime frame
2. The secondary outcomes would be: i. Number of follicles of 18 mm. ii. Endometrial thickness- checked on the day of follicular development. iii. Clinical pregnancy rate. Timepoint: i. 13-15 days ii. 13-15 days iii. 6 weeks

Countries

India

Contacts

Public ContactDr Abha Khurana

Bangalore Baptist Hospital

gkorula@gmail.com8197616200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026